NCT07273903

Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-01-15Est. Completion: 2028-01

Enrollment target: 35 participants

Locations

University Hospital Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
University Hospital Münster, Münster, North Rhine-Westphalia, Germany

Contact

Marc G Pawlitzki, PD Dr. med.neuro-trials@med.uni-duesseldorf.de +49 02118117887

Other microbiome trials you might be interested in

A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating PolyradiculoneuropathyPhase 2Recruiting

Chronic Inflammatory Demyelinating PolyradiculoneuropathyCIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

The main purpose of the study is to determine the correct dose of empasiprubart in adolescent participants. It also aims…

Multiple LocationsEst. completion Apr 2028

View Trial →

Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP.TERMINATED

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathies (CIDP) are acquired, autoimmune and inflammatory neuropathies leadin…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.